secwatch.observer — SEC 8-K summary
======================================

Issuer:     Processa Pharmaceuticals, Inc. (PCSA)
CIK:        0001533743
Form:       8-K
Filed at:   2024-04-04T23:59:59+00:00
Accession:  0001493152-24-013132
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Processa CEO presents at MedInvest conference; no specific material data in filing
--------------------------------------------------------------------------------

- CEO George Ng presented at MedInvest Biotech + Pharma Investor Conference on April 3, 2024 in NYC.
- Presentation titled 'Next Generation Chemotherapy: Improved Treatment for More Patients' was at 10:55 AM ET.
- President R&D David Young attended the meeting virtually.
- Presentation furnished as Exhibit 99.1 but not included in this filing; no numbers or clinical data disclosed.
- Company directs investors to website for presentation and routine disclosure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533743/000149315224013132/0001493152-24-013132-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533743/000149315224013132/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-013132

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer